Atea Pharmaceuticals, Inc.
USD4.72
-0.05 (-1.05%)
CEO
Jean-Pierre Sommadossi
IPO Date
2020-10-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.73
Prev. Close
$4.78
Day Low
$4.67
Day High
$4.78
52W Low
$2.78
52W High
$6.45
Market Cap
$0.38B
Volume
0.03M
| 29,600 |
| $0.00 |
| 23 Jun 2026 | Lucidi Bruno | director | A-Award | Acquired | 26,700 | $0.00 |
| 23 Jun 2026 | Lucidi Bruno | director | A-Award | Acquired | 37,700 | $4.36 |
| 23 Jun 2026 | BERGER FRANKLIN M | director | M-Exempt | Acquired | 29,600 | $0.00 |
| 23 Jun 2026 | BERGER FRANKLIN M | director | M-Exempt | Disposed | 29,600 | $0.00 |
| 23 Jun 2026 | BERGER FRANKLIN M | director | A-Award | Acquired | 26,700 | $0.00 |
| 23 Jun 2026 | BERGER FRANKLIN M | director | A-Award | Acquired | 37,700 | $4.36 |
| 23 Jun 2026 | Berman Howard | director | A-Award | Acquired | 26,700 | $0.00 |
| 23 Jun 2026 | Berman Howard | director | A-Award | Acquired | 37,700 | $4.36 |